GL1X · GenesisL1 explorer

Research workbench

Crystal structure of candida albicans acetohydroxyacid synthase in complex with the herbicide iodomuron ethyl

Analyse Crystal structure of candida albicans acetohydroxyacid synthase in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6DEN
Type
protein
Length
599 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Acetolactate synthase
EC
2.2.1.6
UniProt
A0A1D8PJF9
Ligands
G8A, FAD, TP9, K, MG, CO2
Pockets
5 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAcetolactate synthase (EC 2.2.1.6)protein59943% helix, 17% strandA0A1D8PJF9

Ligands and binding sites

  • G8A · Ethyl 2-{[(4-iodo-6-methoxypyrimidin-2-yl) carbamoyl]sulfamoyl}benzoate · ligand · chains A
  • FAD · Flavin-adenine dinucleotide · ligand · chains A
  • TP9 · (3Z)-4-{[(4-amino-2-methylpyrimidin-5-yl)methyl]amino}-3-mercaptopent-3-en-1-yl trihydrogen diphosphate · ligand · chains A
  • K · Potassium ion · metal · chains A
  • MG · Magnesium ion · metal · chains A
  • CO2 · Carbon dioxide · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15550.810.8777FAD, TP9, CO2
21290.560.8322empty
31460.530.8027empty
41070.360.7416empty
5570.280.7411empty

Compared structures

  • 6DEN · Crystal structure of Candida albicans acetohydroxyacid synthase in complex with the… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.